Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Assist Reprod Genet ; 34(10): 1289-1294, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28624859

RESUMO

PURPOSE: The functional role of the FSHR promoter -29G/A polymorphism (rs1394205) in men is not clear. Some studies failed to find a relationship between the FSHR -29G/A and follicle-stimulating hormone (FSH) levels and did not associate the SNP with male infertility. Only one study showed that the FSHR -29 SNP modulates serum FSH levels in Baltic young male cohort. Because the SNP -29G/A has to be shown to have a strong effect on in vitro transcription activity of the FSHR promoter and the activation of FSHR is necessary for a normal FSH function, this study was undertaken to assess whether the FSHR -29G/A SNP modulates the gonadal endocrine function in men. METHODS: A total of 200 men with alteration of conventional sperm parameters or normozoospermia (according to the parameters WHO 2010), were genotyped by TaqMan Assay. Hormone levels were measured by immunoassay, and sperm analysis was performed according to the World Health Organization criteria. RESULTS: A significant gradient of increasing FSH levels across the FSHR -29G/A genotypes was observed (p < 0.01). Among normozoospermic men (n = 110), those with FSHR -29A-allele carriers (GA + AA and AA) had higher serum FSH (p < 0.01) and LH levels (p < 0.05) and higher body mass index (BMI) (p < 0.01) compared to men with the GG genotype. The carrier status of rs1394205 genotypes did not affect the other endocrine parameters neither in men with altered sperm parameters nor in normozoospermic men. CONCLUSIONS: The FSHR -29G/A polymorphism modulates FSH and, for the first time, LH serum levels and BMI in normozoospermic men. These findings underline the importance to pay close attention to the studies of genetic variations associated with clinical-endocrine parameters.


Assuntos
Hormônio Foliculoestimulante/sangue , Hormônio Luteinizante/sangue , Polimorfismo de Nucleotídeo Único , Receptores do FSH/genética , Adulto , Índice de Massa Corporal , Hormônio Foliculoestimulante/genética , Frequência do Gene , Humanos , Itália , Hormônio Luteinizante/genética , Masculino , Espermatozoides/fisiologia , Testosterona/sangue
2.
J Assist Reprod Genet ; 34(5): 671-676, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28281143

RESUMO

PURPOSE: The FSHB gene -211G/T polymorphism has been reported to modulate gene expression and to cause inter-individual differences in FSH serum levels in men. This study was undertaken to assess the functional relevance of this polymorphism on gonadotropin and total testosterone serum levels and sperm parameters in men from Eastern Sicily (Italy). METHODS: To accomplish this, 200 men with abnormal conventional sperm parameters or normozoospermia (according to the parameters of WHO 2010) were genotyped by TaqMan Assay. RESULTS: The frequency of FSHB -211 T allele was significantly higher (p < 0.005) in patients with altered conventional sperm parameters (18.9% of chromosomes) compared to that observed in men with normozoospermia (10.9% of chromosomes). Decreasing serum levels of FSH and LH were observed across the three FSHB -211 genotype subgroups (p < 0.001 and p < 0.05, respectively). In addition, the FSHB -211G/T polymorphism showed a total testosterone downward trend that became more evident in men with the TT genotype compared to subjects with the GG genotype (p = 0.05). Furthermore, we found a trend towards decreased sperm concentration, total sperm count, sperm forward motility and testicular volume in men with GT and TT genotypes. CONCLUSIONS: These findings showed that the FSHB -211 G/T polymorphism modulates male gonadal function with a clear influence on hormonal levels and sperm parameters. CAPSULE: The present study was undertaken to evaluate the distribution of the FSHB -211 G/T in men with normal or abnormal sperm parameters from Southern Italy to assess its functional relevance on the serum levels of reproductive hormones and on sperm parameters in men.


Assuntos
Proteínas de Transporte/sangue , Glicopeptídeos/sangue , Gônadas/crescimento & desenvolvimento , Espermatozoides/metabolismo , Adulto , Alelos , Proteínas de Transporte/genética , Regulação da Expressão Gênica no Desenvolvimento , Frequência do Gene , Genótipo , Glicopeptídeos/genética , Gonadotropinas/sangue , Gônadas/metabolismo , Humanos , Itália , Masculino , Polimorfismo de Nucleotídeo Único , Contagem de Espermatozoides , Espermatozoides/ultraestrutura , Testosterona/sangue
3.
Reprod Biomed Online ; 17(1): 27-35, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18616886

RESUMO

Mutations of the cystic fibrosis transmembrane regulator (CFTR) gene and polymorphisms, such as the (TG)m and Tn polymorphic loci in intron 8 at the splice acceptor site of exon 9, can cause male infertility. The aim of this study was to investigate the frequency of the most prevalent cystic-fibrosis-causing mutations, the IVS8-Tn alleles and IVS8-TG12 variant in the presence of IVS8-5T in patients with altered semen parameters (group I with obstructive azoospermia, group II with secretory azoospermia and group III with severe oligozoospermia) compared with a control group with normozoospermia. CFTR mutations were found in 26.5% and 14.3% of chromosomes of patients of group I and II respectively (P < 0.001, P < 0.05). The frequency of the 5T allele was 23.5% in patients in group I (P < 0.01), and was linked exclusively with TG12 allele. The present study reports for the first time a high proportion of the 5T allele in patients in group III (9.2%, P < 0.05). These results underline the importance of performing molecular analysis of mutations and IVS8-Tn polymorphism in the CFTR gene and appropriate genetic counselling to all couples undergoing assisted reproductive technologies when the partner has azoospermia or severe oligozoospermia.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Infertilidade Masculina/terapia , Mutação , Polimorfismo Genético , Alelos , Azoospermia/genética , Análise Mutacional de DNA , Éxons , Aconselhamento Genético , Genótipo , Humanos , Íntrons , Masculino , Oligospermia/genética , Contagem de Espermatozoides
4.
J Neurol Sci ; 165(2): 121-5, 1999 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-10450796

RESUMO

We have studied two large unrelated Finnish families with myophosphorylase deficiency (McArdle's disease). In one, we identified a new nonsense mutation at codon 540 in exon 14 of the myophosphorylase gene, changing an encoded glutamic acid to a stop codon (E540X). The second family carried a splice-junction mutation at the 5' splice site of intron 14 (1844+G-->A), previously reported in one Caucasian patient and in a consanguineous Druze family. These data further enlarge the list of mutations associated with McArdle's disease and establish that McArdle's disease is genetically heterogeneous also within the Finnish population.


Assuntos
Doença de Depósito de Glicogênio Tipo V/genética , Adulto , Códon sem Sentido , DNA/genética , Feminino , Finlândia , Doença de Depósito de Glicogênio Tipo V/metabolismo , Doença de Depósito de Glicogênio Tipo V/patologia , Humanos , Músculo Esquelético/patologia , Mutação , Linhagem , Fosforilases/deficiência , Fosforilases/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Trans-Splicing
5.
Neuromuscul Disord ; 9(3): 171-3, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10382911

RESUMO

We have identified a novel missense mutation, an A-T transition at codon 684 in exon 17, changing an encoded asparagine to a tyrosine (Asn684Tyr) in a Spanish patient with typical McArdle's disease. The patient was a compound heterozygote, with a previously-described mutation (Gly204Ser) on the other allele. This report expands the molecular genetic heterogeneity in McArdle's disease, emphasizes the presence of private mutations in specific ethnic groups, and indicates that geographic origin must be considered before undertaking DNA analysis for diagnosis.


Assuntos
Doença de Depósito de Glicogênio Tipo V/genética , Fosforilases/genética , Adulto , Substituição de Aminoácidos , Asparagina/genética , Sequência de Bases , DNA/química , DNA/genética , Análise Mutacional de DNA , Doença de Depósito de Glicogênio Tipo V/enzimologia , Humanos , Masculino , Mutação de Sentido Incorreto , Espanha , Tirosina/genética
6.
Neuromuscul Disord ; 9(1): 34-7, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10063833

RESUMO

We identified a new mutation in the myophosphorylase gene in a Japanese family with McArdle's disease. This point mutation results in the replacement of a tryptophan at amino acid position 361 with a stop codon, the third nonsense mutation in this disorder. Our findings further expand the already wide spectrum of genetic lesions associated with McArdle's disease, and establish that molecular genetic heterogeneity is also present in the Japanese population.


Assuntos
Doença de Depósito de Glicogênio Tipo V/enzimologia , Doença de Depósito de Glicogênio Tipo V/genética , Mutação de Sentido Incorreto/genética , Fosforilases/genética , Idoso , Feminino , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Biologia Molecular , Linhagem , Fosforilases/deficiência , Polimorfismo de Fragmento de Restrição , Reação em Cadeia da Polimerase Via Transcriptase Reversa
7.
Neurology ; 51(1): 260-2, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9674815

RESUMO

We analyzed leukocyte DNA of 19 patients from 12 Spanish families with McArdle's disease (myophosphorylase deficiency). In 15 patients, the enzyme defect was documented histochemically in muscle, and in four the diagnosis was based on clinical and laboratory data. Three patients were homozygous and six were heterozygous for the nonsense mutation at codon 49 (R49X). Our findings indicate that the R49X mutation, which is common in English and American patients, is also present in Spanish patients with McArdle's disease, but at a lower frequency.


Assuntos
Doença de Depósito de Glicogênio Tipo V/etnologia , Doença de Depósito de Glicogênio Tipo V/genética , Adulto , Alelos , Análise Mutacional de DNA , Feminino , Heterozigoto , Homozigoto , Humanos , Masculino , Mutação , Espanha/epidemiologia
8.
Artigo em Inglês | MEDLINE | ID: mdl-18263064

RESUMO

This paper describes a system based on evolutionary learning, called MORPH, that semi-automates the generation of morphological programs. MORPH maintains a population of morphological programs that is continually enhanced. The first phase of each learning cycle synthesizes morphological sequences that extract novel features which increase the population's diversity. The second phase combines these newly formed operator sequences into larger programs that are better than the individual programs. A stochastic selection process eliminates the poor performers, while the survivors serve as the basis of another learning cycle. Experimental results are presented for binary and grayscale target recognition problems.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...